Found: 29
Select item for more details and to access through your institution.
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice--a longitudinal analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice-a longitudinal analysis.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 1, p. 283, doi. 10.1007/s00520-014-2375-0
- By:
- Publication type:
- Article
Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 174, doi. 10.1111/j.1743-7563.2010.01345.x
- By:
- Publication type:
- Article
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2614, doi. 10.3390/cancers13112614
- By:
- Publication type:
- Article
Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e234261, doi. 10.1001/jamanetworkopen.2023.4261
- By:
- Publication type:
- Article
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: Preliminary evidence of activity in small cell and neuroendocrine carcinomas.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 7, p. 1413, doi. 10.1002/cncr.22522
- By:
- Publication type:
- Article
Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 145, doi. 10.1016/j.clcc.2014.06.004
- By:
- Publication type:
- Article
Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters.
- Published in:
- 2012
- By:
- Publication type:
- journal article
International Cost-Effectiveness Analysis of Durvalumab in Stage III Non–Small Cell Lung Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 5, p. e2413938, doi. 10.1001/jamanetworkopen.2024.13938
- By:
- Publication type:
- Article
Emphysematous Cholecystitis in a Patient with Gastrointestinal Stromal Tumor Treated with Sunitinib.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 5, p. 775, doi. 10.1592/phco.27.5.775
- By:
- Publication type:
- Article
Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore.
- Published in:
- Breast Journal, 2013, v. 19, n. 2, p. 220, doi. 10.1111/tbj.12092
- By:
- Publication type:
- Article
Can biosimilars help achieve the goals of US health care reform?
- Published in:
- Cancer Management & Research, 2017, v. 9, p. 197, doi. 10.2147/CMAR.S133442
- By:
- Publication type:
- Article
Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer.
- Published in:
- Einstein (16794508), 2022, v. 20, p. 1, doi. 10.31744/einstein_journal/2022GS6655
- By:
- Publication type:
- Article
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.
- Published in:
- Einstein (16794508), 2019, v. 17, n. 2, p. 1, doi. 10.31744/einstein_journal/2019GS4414
- By:
- Publication type:
- Article
Custo-efetividade da adição de quimioterapia ao tratamento hormonal do câncer de próstata metastático sensível a hormônio ou localizado de alto risco.
- Published in:
- Einstein (16794508), 2017, v. 15, n. 3, p. 349, doi. 10.1590/S1679-45082017GS4017
- By:
- Publication type:
- Article
imaDisparidades na epidemiologia e no tratamento de câncer nas populações indígenas brasileiras.
- Published in:
- Einstein (16794508), 2016, v. 14, n. 3, p. 330, doi. 10.1590/S1679-45082016AO3754
- By:
- Publication type:
- Article
O impacto do uso do erlotinibe em pacientes portadores de neoplasia de pulmão de não pequenas células tratados em um hospital geral de referência e clínica particular de oncologia no período de 2005 a 2011.
- Published in:
- Einstein (16794508), 2015, v. 13, n. 2, p. 215, doi. 10.1590/S1679-45082015AO3326
- By:
- Publication type:
- Article
Cervical cancer control in Latin America: A call to action.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 4, p. 1032, doi. 10.1002/cncr.26372
- By:
- Publication type:
- Article
The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review.
- Published in:
- Oncologist, 2018, v. 23, n. 3, p. 346, doi. 10.1634/theoncologist.2017-0126
- By:
- Publication type:
- Article
Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1012783
- By:
- Publication type:
- Article
Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non–small cell lung cancer: A network meta‐analysis of randomized trials.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 5, p. 709, doi. 10.1002/cncr.33269
- By:
- Publication type:
- Article
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-592
- By:
- Publication type:
- Article
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu- Overexpressing Breast Cancer in Singapore.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 178, doi. 10.1186/1471-2407-11-178
- By:
- Publication type:
- Article